CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostate cancer biomarker

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 6, 1997, Pages 443-450

  Lee, Wen Hsiang ^a   Isaacs, William B ^a   Steven Bova, G ^a   Nelson, William G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL DNA;

ARTICLE; CANCER CYTODIAGNOSIS; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA;

CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0030954428     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W., De Bustros, A., Vertino, P., and Nelkin, B. D. Abnormal patterns of DNA methylation in human neoplasia: potential for tumor progression. Cancer Cells, 3: 383-390, 1991.
3. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
4. Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D., and Sidransky, D. Molecular detection of primary bladder cancer by microsatellite analysis. Science (Washington DC), 277: 659-662, 1996.
5. Sidransky, D., Von Eschenbach, A., Tsai, Y. C, Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., and Vogelstein, B. Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
6. Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., and Vogelstein, B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (Washington DC), 256:102-105, 1992.
7. Boyle, J. O., Mao, L., Brennan, J. A., Koch, W. M., Eisele, D. W., Saunders, J. R., and Sidransky, D. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am. J. Surg., 768: 429-432, 1994.
8. Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., and Sidransky, D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Nail. Acad. Sci. USA, 91: 9871-9875, 1994.
9. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Enal. J. Med., 332: 429-435, 1995.
10. Lee, W-H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W-S., Isaacs, W. B., and Nelson, W. G. Cylidine melhylation of regulatory sequences near the π-cIass glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Nail. Acad. Sci. USA, 91: 11733-11737, 1994.
11. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
12. Kunimi, K., Bergerheim, U. S., Larsson, I. L., Ekman, P., and Collins, V. P. Allelotyping of human prostatic adenocarcinoma. Genomics, 11: 530-536, 1991.
13. Bergerheim, U. S., Kunimi, K., Collins, V. P., and Ekman, P. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer, 3: 215-220, 1991.
14. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic Iqss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
15. Matsuyama, H., Pan, Y., Skoog, L., Tribukait, B., Naito, K., Ekman, P., Lichter, P., and Bergerheim, U. S. Deletion mapping of chromosome 8p in human prostate cancer by fluorescence in situ hybridization. Oncogene, 9: 3071-3076, 1994.
16. Qian, J., Bostwick, D. G., Takahashi, S., Borell, T. J., Herath, J. F., Lieber, M. M., and Jenkins, R. B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res., 53: 5408-5414, 1995.
17. Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J., Brooks, J. D., and Ewing, C. M. Genetic alterations in prostate cancer. Cold Spring Harb. Symp. Quant. Biol., 59: 653-659, 1994.
18. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, p. 6.45; pp. 9.I6-9.I9. Plainview, NY: Cold Spring Harbor Laboratory, 1989.
19. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
20. Burton, K. Determination of DNA concentration with diphenylamine. Methods Enzymol., 12B: 163-166, 1968.
21. Morrow, C. S., Cowan, K. H., and Goldsmith, M. E. Structure of the human genomic glutathione S-transferase π gene. Gene (Amst.) 75: 3-11, 1989.
22. Cross, S. H., and Bird, A. P. CpG islands and genes. Curr. Opin. Genet. Dev., 5:309-314, 1995.
23. Pfiefer, G. P., Tnaguay, S. D., Steigerman, S. D., and Riggs, A. D. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev., 4: 1277-1287, 1990.
24. Homstra, I. K., and Yang, T. P. High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5' region on the active and inactive X chromosomes: correlation with binding sites for transcription factors. Mol. Cell. Biol., 14: 1419-1430. 1994.
25. McNeal, J. E., and Bostwick, D. G. Intraductal dysplasia: a premalignant lesion of the prostate. Hum. Pathol., 17: 64-71, 1986.
26. Grigg, G., and Clark, S. Sequencing 5-methylcytosine residues in genomic DNA. Bioessays, 16: 431-436, 1994.
27. Mueller, P. R., and Wold, B. In vivo footprinting at a developmentally regulated enhancer. Science (Washington DC), 246: 780-786, 1989.
28. Pfiefer, G. P., Steigerwald, S. D., Mueller, P. R., Wold, B., and Riggs, A. D. Genomic sequencing and methylation analysis by ligation mediated PCR. Science (Washington DC), 246: 810-813, 1989.
29. Frommer, M., McDonald, L. E., Millar, D. S., Collins, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
30. Singer-Sam, J., Le Bon, J. M., Tanguay, R. L., and Riggs, A. D. A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. Nucleic Acids Res., 18: 687, 1990.
31. Fukuhara, T., Hooper, W. C., Baylin, S. B., Benson, J., Prucker, J., Olson, A. C., Evatt, B. L., and Vogler, W. R. Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene: a new, sensitive approach to monitor tumor cells in acute myelogenous leukemia. Leuk. Res., 16: 1031-1040, 1992.
32. Life Technologies, Inc. Product Catalogue and Reference Guide 1995-1996. Gaithersburg, Maryland, 1995.
33. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G., and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
34. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C, Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765-775, 1994.
35. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haitom, E., Gaynes, L., Kaplan, L, Bubley, G., DeWolf, W., and Sklar J. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634-2639, 1994.
36. Ghossein, R. A., Sher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F., and Rosai, J. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195-1200, 1995.
37. Israeli, R. S., Miller, W. H., Su, S. L., Samadi, D. S., Powell, C. T., Heston, W. D., Wise, G. J., and Fair, W. R. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J. Urol., 153: 573-577, 1995.
38. Loric, S., Dumas, F., Eschwege, P., Blanche!, P., Benoit, G., Jardin, A., and Lacour, B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem., 41: 1698-1704, 1995.
39. Macoska, J. A., Trybus, T. M., Sakr, W. A., Wolf, M. C., Benson, P. D., Powell, I. J., and Pontes, J. E. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res., 54: 3824-3830, 1994.
40. Emmert-Buck, M. R., Vocker, C. D., Pozatti, R.O., Duray, P. H., Jennings, S. B., Florence, C. D., Zhuang, Z., Bostwick, D. G., Liotta, L. A., and Linehan, W. M. Allelic loss in chromosome 8pl2-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res., 55: 2959-2962, 1995.